Aurora Cannabis Inc., a leading Canadian-based global medical cannabis company, has reported its financial and operational ...

Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the ...

NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...

The 37% increase from the prior period was mainly due to 51% growth in the global medical cannabis business and 22% growth in the plant ...

Walt Disney Co. reported first-quarter earnings as the company faces a number of challenges, despite recent box office ...

Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 billion. On the basis of U.S. generally ...

Q4 2024 Management View CEO Kevin Hykes highlighted strong revenue growth of $15.3 million for Q4 2024, representing a 36% increase year-over-year. U.S. Heart Failure revenues grew by 41%, supported ...

Oscar gained market share in key states such as Florida, Tennessee, and Texas, while achieving strong results in new markets like North Carolina. Membership reached 1.8 million as of February 1, 2025, ...

MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. ("CVRx"), a commercial-stage medical device company focused on ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.